Advanced search
Publication Cover
Clinical Epidemiology Volume 9, 2017 - Issue
Submit an article Journal homepage
83
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study

Mikkel Z Ankarfeldt1 Novo Nordisk A/S, Bagsvaerd, Denmark;2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the NetherlandsCorrespondence[email protected]
,
Brian L Thorsted1 Novo Nordisk A/S, Bagsvaerd, Denmark
,
Rolf HH Groenwold2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands;3 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, the Netherlands
,
Erpur Adalsteinsson1 Novo Nordisk A/S, Bagsvaerd, Denmark
,
M Sanni Ali2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands;3 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, the Netherlands;4 Nuffield Department of Orthopaedics, Rheumatology, Musculoskeletal Sciences, University of Oxford, Oxford, UK
&
Olaf H Klungel2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands;3 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, the Netherlands
Pages 19-30 | Published online: 18 Jan 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carl Samuelsen, Jonathan Lim, Amanda Golembesky, Sulena Shrestha, Li Wang & Ingolf Griebsch. (2020) Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States. Journal of Medical Economics 23:1, pages 48-53.
Read now

Articles from other publishers (7)

Danielle S. Abraham, Thanh Phuong Pham Nguyen, Leah J. Blank, Dylan Thibault, Shelly L. Gray, Sean Hennessy, Charles E. Leonard, Daniel Weintraub & Allison W. Willis. (2023) Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies. Neurotherapeutics 20:2, pages 375-388.
Crossref
Ida Kim Wium‐Andersen, Marie Kim Wium‐Andersen, Anders Fink‐Jensen, Jørgen Rungby, Martin Balslev Jørgensen & Merete Osler. (2022) Use of GLP‐1 receptor agonists and subsequent risk of alcohol‐related events. A nationwide register‐based cohort and self‐controlled case series study. Basic & Clinical Pharmacology & Toxicology 131:5, pages 372-379.
Crossref
Ida Kim Wium-Andersen, Merete Osler, Martin Balslev Jørgensen, Jørgen Rungby & Marie Kim Wium-Andersen. (2022) Diabetes, antidiabetic medications and risk of depression – A population-based cohort and nested case-control study. Psychoneuroendocrinology 140, pages 105715.
Crossref
Luigi F. Meneghini, Sean D. Sullivan, Gerry Oster, Robert Busch, Anna M. G. Cali, Arnaud Dauchy, Jasvinder Gill & Timothy S. Bailey. (2020) A pragmatic randomized clinical trial of insulin glargine 300 U/ mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study . Diabetes, Obesity and Metabolism 22:11, pages 2004-2012.
Crossref
Daniel B. Horton, Harshvinder Bhullar, Lucy Carty, Francesca Cunningham, Alexis Ogdie, Janet Sultana & Gianluca Trifirò. 2019. Pharmacoepidemiology. Pharmacoepidemiology 241 289 .
Jonathan Lim, Carl Samuelsen, Amanda Golembesky, Sulena Shrestha, Li Wang & Ingolf Griebsch. (2019) Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA. Future Oncology 15:13, pages 1493-1504.
Crossref
Cory N. Criss & Samir K. Gadepalli. (2018) Sponsoring surgeons: An investigation on the influence of the da Vinci robot. The American Journal of Surgery 216:1, pages 84-87.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.